114 related articles for article (PubMed ID: 29157028)
1. Enhanced selective cellular uptake and cytotoxicity of epidermal growth factor-conjugated liposomes containing curcumin on EGFR-overexpressed pancreatic cancer cells.
Le UM; Hartman A; Pillai G
J Drug Target; 2018 Sep; 26(8):676-683. PubMed ID: 29157028
[TBL] [Abstract][Full Text] [Related]
2. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
3. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J
PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.
Arnoletti JP; Buchsbaum DJ; Huang ZQ; Hawkins AE; Khazaeli MB; Kraus MH; Vickers SM
J Gastrointest Surg; 2004 Dec; 8(8):960-9; discussion 969-70. PubMed ID: 15585383
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
[TBL] [Abstract][Full Text] [Related]
7. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
Matsuda K; Idezawa T; You XJ; Kothari NH; Fan H; Korc M
Cancer Res; 2002 Oct; 62(19):5611-7. PubMed ID: 12359775
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.
Lev-Ari S; Starr A; Vexler A; Karaush V; Loew V; Greif J; Fenig E; Aderka D; Ben-Yosef R
Anticancer Res; 2006; 26(6B):4423-30. PubMed ID: 17201164
[TBL] [Abstract][Full Text] [Related]
9. EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model.
Zalba S; Contreras AM; Merino M; Navarro I; de Ilarduya CT; Trocóniz IF; Koning G; Garrido MJ
Nanomedicine (Lond); 2016; 11(5):465-77. PubMed ID: 26892017
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
11. Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles.
Grapa CM; Mocan T; Gonciar D; Zdrehus C; Mosteanu O; Pop T; Mocan L
Int J Nanomedicine; 2019; 14():9693-9706. PubMed ID: 31849462
[TBL] [Abstract][Full Text] [Related]
12. Effects of antisense epidermal growth factor and its receptor retroviral expression vectors on cell growth of human pancreatic carcinoma cell line.
Liu T; Chen J; Zeng C
Chin Med J (Engl); 1995 Sep; 108(9):653-9. PubMed ID: 8575229
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Czyzewska J; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):667-71. PubMed ID: 20430737
[TBL] [Abstract][Full Text] [Related]
14. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR
Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964
[TBL] [Abstract][Full Text] [Related]
15. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
[TBL] [Abstract][Full Text] [Related]
16. Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor.
Ozaki N; Ohmuraya M; Hirota M; Ida S; Wang J; Takamori H; Higashiyama S; Baba H; Yamamura K
Mol Cancer Res; 2009 Sep; 7(9):1572-81. PubMed ID: 19737965
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles.
Jung KH; Lee JH; Park JW; Kim DH; Moon SH; Cho YS; Lee KH
Oncol Lett; 2018 Jun; 15(6):9093-9100. PubMed ID: 29805641
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human pancreatic cancer cell (MIA PaCa-2) growth by cholera toxin and 8-chloro-cAMP in vitro.
Ohmura E; Wakai K; Isozaki O; Murakami H; Onoda N; Emoto N; Shizume K; Tsushima T; Demura H; Robins RK
Br J Cancer; 1993 Feb; 67(2):279-83. PubMed ID: 8381655
[TBL] [Abstract][Full Text] [Related]
19. Expression of and response to growth regulatory peptides by two human pancreatic carcinoma cell lines.
Beauchamp RD; Lyons RM; Yang EY; Coffey RJ; Moses HL
Pancreas; 1990 Jul; 5(4):369-80. PubMed ID: 2199964
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical study on epidermal growth factor and its receptor in human pancreatic carcinoma].
Yamanaka Y; Onda M; Uchida E; Kobayashi T; Sasajima K; Tokunaga A; Tajiri T; Egami K; Asano G
Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1544-50. PubMed ID: 2214281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
